BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 10843746)

  • 21. Activation, proliferation, and differentiation of circulating B cells in autoimmune thyroid disease.
    Weetman AP; Volkman DJ; Burman KD; Fauci AS
    J Immunol; 1985 Nov; 135(5):3138-43. PubMed ID: 3876377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thyroid autoantigen-induced lymphocyte proliferation in Graves' disease and Hashimoto's thyroiditis.
    Weetman AP; Gunn C; Hall R; McGregor AM
    J Clin Lab Immunol; 1985 May; 17(1):1-6. PubMed ID: 3876444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The balance shift in Th1/Th2 related IL-12/IL-5 cytokines in Graves' disease during methimazole therapy.
    Molnár I
    Autoimmunity; 2007 Feb; 40(1):31-7. PubMed ID: 17364495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of CD23 hyperexpression on B cells from patients with rheumatoid arthritis.
    De Miguel S; Galocha B; Jover JA; Bañares A; Hernández-García C; García-Asenjo JA; Fernández-Gutiérrez B
    J Rheumatol; 2001 Jun; 28(6):1222-8. PubMed ID: 11409113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defective major histocompatibility complex class I expression on lymphoid cells in autoimmunity.
    Fu Y; Nathan DM; Li F; Li X; Faustman DL
    J Clin Invest; 1993 May; 91(5):2301-7. PubMed ID: 8486790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased serum concentration of interleukin-5 in patients with Graves' disease and Hashimoto's thyroiditis.
    Hidaka Y; Okumura M; Shimaoka Y; Takeoka K; Tada H; Amino N
    Thyroid; 1998 Mar; 8(3):235-9. PubMed ID: 9545110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD5+ B cells in Graves' disease: correlation with disease activity.
    Corrales JJ; Orfao A; López A; Mories MT; Miralles JM; Ciudad J
    Horm Metab Res; 1996 Jun; 28(6):280-5. PubMed ID: 8811329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinoic acid inhibits CD40 plus IL-4 mediated IgE production through alterations of sCD23, sCD54 and IL-6 production.
    Scheffel F; Heine G; Henz BM; Worm M
    Inflamm Res; 2005 Mar; 54(3):113-8. PubMed ID: 15883744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activated (Ia+) T-lymphocytes and their subsets in autoimmune thyroid diseases: analysis by dual laser flow microfluorocytometry.
    Chan JY; Walfish PG
    J Clin Endocrinol Metab; 1986 Feb; 62(2):403-9. PubMed ID: 3484483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of interleukins on EGF-stimulated growth promotion in human thyroid cells: differential modifications by IL-2 and IL-6 in Graves' and normal thyroid cells.
    Shimomura N; Itoh M; Okugawa T; Murata Y; Seo H
    Endocr Regul; 1994 Jun; 28(2):55-65. PubMed ID: 7949016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TLR7/8 ligand, R-848, inhibits IgE synthesis by acting directly on B lymphocytes.
    Shen E; Lu L; Wu C
    Scand J Immunol; 2008 Jun; 67(6):560-8. PubMed ID: 18397197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneity of immunoregulatory T cells in human thyroid autoimmunity: influence of thyroid status.
    Bonnyns M; Bentin J; Devetter G; Duchateau J
    Clin Exp Immunol; 1983 Jun; 52(3):629-34. PubMed ID: 6223729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin 10 induces B lymphocytes from IgA-deficient patients to secrete IgA.
    Brière F; Bridon JM; Chevet D; Souillet G; Bienvenu F; Guret C; Martinez-Valdez H; Banchereau J
    J Clin Invest; 1994 Jul; 94(1):97-104. PubMed ID: 7518836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T-T cell interactions in patients with endocrine autoimmunity. Definition of antiergotypic T lymphocytes.
    Wilfing A; Gessl A; Czernin S; Förster O; Grubeck-Loebenstein B
    Horm Metab Res; 1993 Dec; 25(12):628-31. PubMed ID: 8119667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of cell morphology in B lymphocytes by IL-4: evidence for induced cytoskeletal changes.
    Davey EJ; Thyberg J; Conrad DH; Severinson E
    J Immunol; 1998 Jun; 160(11):5366-73. PubMed ID: 9605136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased serum concentration of interleukin-12 in patients with silent thyroiditis and Graves' disease.
    Hidaka Y; Okumura M; Fukata S; Shimaoka Y; Takeoka K; Tada H; Kuma K; Amino N
    Thyroid; 1999 Feb; 9(2):149-53. PubMed ID: 10090314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of cellular immunity in patients with Graves' disease.
    Takaishi M; Kobuke K; Akiyama M; Hara H; Yamakido M
    Hiroshima J Med Sci; 1990 Dec; 39(4):109-13. PubMed ID: 2086560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro effects of cytokines and human thyroglobulin on the induction of antibody-secreting cells in patients with auto-immune thyroid disease.
    Resetkova E; Morita T; Akasu F; Carayon P; Volpé R
    Clin Invest Med; 1993 Aug; 16(4):256-64. PubMed ID: 8306534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ligation of CD23 triggers cyclic AMP generation in human B lymphocytes.
    Kolb JP; Abadie A; Paul-Eugene N; Capron M; Sarfati M; Dugas B; Delespesse G
    J Immunol; 1993 Jun; 150(11):4798-809. PubMed ID: 8388420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-27 induces the production of IgG1 by human B cells.
    Boumendjel A; Tawk L; Malefijt Rde W; Boulay V; Yssel H; Pène J
    Eur Cytokine Netw; 2006 Dec; 17(4):281-9. PubMed ID: 17353163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.